ClinicalTrials.Veeva

Menu

Protein Supply in Elderly

Maastricht University Medical Centre (MUMC) logo

Maastricht University Medical Centre (MUMC)

Status

Completed

Conditions

Muscle Synthesis

Treatments

Dietary Supplement: Protein

Study type

Interventional

Funder types

Other

Identifiers

NCT01317511
MEC 09-3-078.3

Details and patient eligibility

About

Stimulating overnight muscle protein synthesis, might augment muscle hypertrophy, increase mitochondrial mass, and/or improve muscle tissue repair. The goal of this proposal will be to provide further insight into the responsiveness of the muscle protein synthetic machinery to food intake in relation to age.

Enrollment

16 patients

Sex

Male

Ages

65 to 80 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Males
  • Age between 65 and 80 years
  • BMI < 30 kg/m2

Exclusion criteria

  • Type 2 diabetic patients
  • Use of medication
  • All co morbidities interacting with mobility and muscle metabolism of the lower limbs (e.g. artrosis, arthritis, spasticity/rigidity, all neurological disorders and paralysis).
  • Use of anticoagulants, blood diseases, allergy for lidocain.
  • Contra indications for the use of a nasogastric tube: high risk of aspiration, gastric stasis, gastro-oesophageal reflux, upper gastrointestinal stricture, nasal injuries and base of skull fractures.
  • Patients suffering from PKU (Phenylketonuria).

Trial design

Primary purpose

Basic Science

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Double Blind

16 participants in 2 patient groups, including a placebo group

Protein
Experimental group
Description:
Protein drink
Treatment:
Dietary Supplement: Protein
Placebo
Placebo Comparator group
Description:
water
Treatment:
Dietary Supplement: Protein

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems